Evogene (EVGN) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts EVGN Hot Sheet
Join SI Premium – FREE
Evogene (NASDAQ: EVGN) reported Q1 EPS of ($0.21), $0.02 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $312 thousand versus the consensus estimate of $230.67 thousand.
For earnings history and earnings-related data on Evogene (EVGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evogene Schedules Second Quarter 2026 Financial Results Release
- Short sellers pile into SpaceX ahead of earnings, lockup expiration
- enVVeno Medical (NVNO) Misses Q2 EPS by 537c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
